10:54 AM EST, 11/06/2026 (MT Newswires) -- Eli Lilly (LLY.F) agreed to expand access to its weight-loss drugs Zepbound and Foundayo through US telehealth company Him & Hers Health's (82W.F) consumer platform. Under the agreement, eligible patients with prescriptions from licensed providers on the platform can access self-pay prices for both drugs and have the medications delivered to their homes, the US pharmaceutical company said Friday.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.